$0.02
LumiraDx Limited is a diagnostics & research business based in the US. LumiraDx Limited shares (LMDX) are listed on the NASDAQ and all prices are listed in US Dollars. LumiraDx Limited employs 1,210 staff and has a trailing 12-month revenue of around $126.5 million.
Our top picks for where to buy LumiraDx stock
How to buy LumiraDx Limited stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LMDX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy LumiraDx Limited stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
LumiraDx Limited stock price (NASDAQ: LMDX)
Use our graph to track the performance of LMDX stocks over time.LumiraDx Limited shares at a glance
Latest market close | $0.02 |
---|---|
52-week range | $0.01 - $0.49 |
50-day moving average | $0.08 |
200-day moving average | $0.30 |
Wall St. target price | $0.65 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.08 |
Is it a good time to buy LumiraDx Limited stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
LumiraDx Limited price performance over time
Historical closes compared with the close of $0.016 from 2024-04-04
1 week (2024-07-13) | N/A |
---|---|
1 month (2024-06-20) | N/A |
3 months (2024-04-20) | N/A |
6 months (2024-01-24) | 60.00% |
1 year (2023-07-24) | -96.18% |
---|---|
2 years (2022-07-22) | -98.86% |
3 years (2021-07-23) | 9.89 |
5 years (2019-07-20) | N/A |
LumiraDx Limited financials
Revenue TTM | $126.5 million |
---|---|
Gross profit TTM | $61 million |
Return on assets TTM | -28.04% |
Return on equity TTM | -1564.48% |
Profit margin | -267.19% |
Book value | $-0.67 |
Market Capitalization | $249.6 million |
TTM: trailing 12 months
LumiraDx Limited share dividends
We're not expecting LumiraDx Limited to pay a dividend over the next 12 months.
LumiraDx Limited share price volatility
Over the last 12 months, LumiraDx Limited's shares have ranged in value from as little as $0.0075 up to $0.486. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LumiraDx Limited's is 1.713. This would suggest that LumiraDx Limited's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put LumiraDx Limited's beta into context you can compare it against those of similar companies.
- Altimmune (ALT.US): 0.114
- Veradigm (MDRX.US): 0.627
- Landec Corporation (LNDC.US): 1.1023
LumiraDx Limited overview
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom. .
Frequently asked questions
What percentage of LumiraDx Limited is owned by insiders or institutions?Currently 55.41% of LumiraDx Limited shares are held by insiders and 25.266% by institutions. How many people work for LumiraDx Limited?
Latest data suggests 1,210 work at LumiraDx Limited. When does the fiscal year end for LumiraDx Limited?
LumiraDx Limited's fiscal year ends in December. Where is LumiraDx Limited based?
LumiraDx Limited's address is: 3 More London Riverside, London, United Kingdom, SE1 2AQ What is LumiraDx Limited's ISIN number?
LumiraDx Limited's international securities identification number is: KYG5709L1095
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question